SLI
2.019,59
PKT
+11,20
PKT
+0,56
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.02.17 | Zurich Insurance buy | Baader Bank | |
09.02.17 | Zurich Insurance Verkaufen | DZ BANK | |
09.02.17 | Holcim buy | Deutsche Bank AG | |
09.02.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
09.02.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
09.02.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
09.02.17 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
08.02.17 | ABB (Asea Brown Boveri) Sell | S&P Capital IQ | |
08.02.17 | Zurich Insurance Neutral | Macquarie Research | |
07.02.17 | UBS Hold | Deutsche Bank AG | |
07.02.17 | Zurich Insurance Reduce | Commerzbank AG | |
07.02.17 | Swiss Re Reduce | Commerzbank AG | |
07.02.17 | UBS Neutral | Merrill Lynch & Co., Inc. | |
06.02.17 | Swiss Re Underweight | Barclays Capital | |
06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
03.02.17 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.02.17 | Givaudan Neutral | UBS AG | |
03.02.17 | Holcim Neutral | JP Morgan Chase & Co. | |
03.02.17 | Givaudan neutral | Kepler Cheuvreux | |
03.02.17 | Nestlé buy | Goldman Sachs Group Inc. | |
02.02.17 | Roche overweight | Morgan Stanley | |
02.02.17 | Roche overweight | JP Morgan Chase & Co. | |
02.02.17 | UBS Hold | Commerzbank AG | |
02.02.17 | Roche buy | Deutsche Bank AG | |
02.02.17 | Roche Hold | HSBC | |
02.02.17 | Givaudan Underperform | Bernstein Research | |
01.02.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
01.02.17 | Roche Hold | Baader Bank | |
01.02.17 | Givaudan buy | Baader Bank | |
01.02.17 | UBS Hold | Deutsche Bank AG | |
01.02.17 | Swiss Re Sell | UBS AG | |
01.02.17 | Givaudan Hold | Deutsche Bank AG | |
01.02.17 | Givaudan overweight | JP Morgan Chase & Co. | |
01.02.17 | Givaudan Sell | Citigroup Corp. | |
01.02.17 | Holcim overweight | Morgan Stanley | |
01.02.17 | Holcim kaufen | HSBC | |
31.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
31.01.17 | UBS Underperform | BNP PARIBAS | |
31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.01.17 | UBS overweight | Barclays Capital |